Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene
- PMID: 3837844
- PMCID: PMC369162
- DOI: 10.1128/mcb.5.12.3345-3356.1985
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene
Abstract
We studied the effect of altered c-myc structure and expression upon the ability of c-myc to promote the transformation of normal rat embryo cells when it was supplemented by EJras (the mutant c-H-ras1 gene from EJ/T24 bladder carcinoma cells). We tested several c-myc alleles cloned from normal and tumor tissues of chicken and human origin and found that only LL4myc (derived from a bursal lymphoma in which an avian leukosis virus long terminal repeat resides within the first c-myc intron in the same transcriptional orientation) had cotransforming activity. No activity was observed with normal chicken and human c-myc alleles, two other bursal lymphoma c-myc alleles (LL3myc and LL6myc), and two human c-myc genes (HSRmyc and DMmyc) from human neuroectodermal tumor cell line COLO320, in which c-myc is amplified. Some of these inactive alleles had the following alterations that are frequently found in tumor-derived c-myc: point mutations affecting the encoded protein (LL3myc); a truncated structure with loss of the first, noncoding exon (LL3myc and DMmyc); and proviral integration within or near the myc locus (LL3myc and LL6myc). The following two experimental approaches indicated that cotransforming activity was directly related to the transcriptional activity of the alleles in cultured rat cells: when cotransfected into Rat-2 cells, LL4myc was more highly expressed than the other (inactive) alleles; and augmented expression of HSRmyc, DMmyc, or normal human or normal chicken c-myc placed under the transcriptional control of retroviral long terminal repeats or increased expression of normal human c-myc under the influence of a retroviral enhancer element was accompanied by cotransformation activity. We concluded that augmented expression of even a normal c-myc gene is sufficient for cotransforming activity and that additional structural alterations frequently found in tumor-derived alleles are neither necessary nor sufficient for the gene to acquire rat embryo cell cotransforming properties.
Similar articles
-
Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors.Proc Natl Acad Sci U S A. 1984 Feb;81(3):843-7. doi: 10.1073/pnas.81.3.843. Proc Natl Acad Sci U S A. 1984. PMID: 6322173 Free PMC article.
-
Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.J Virol. 1986 Aug;59(2):341-53. doi: 10.1128/JVI.59.2.341-353.1986. J Virol. 1986. PMID: 3016301 Free PMC article.
-
Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.Mol Cell Biol. 1992 Jul;12(7):3130-7. doi: 10.1128/mcb.12.7.3130-3137.1992. Mol Cell Biol. 1992. PMID: 1620120 Free PMC article.
-
Myc family of cellular oncogenes.J Cell Biochem. 1987 Apr;33(4):257-66. doi: 10.1002/jcb.240330404. J Cell Biochem. 1987. PMID: 3034933 Review.
-
Possible role of the first intron of c-H-ras in gene expression: anti-cancer elements in oncogenes.Anticancer Res. 1988 Sep-Oct;8(5A):851-9. Anticancer Res. 1988. PMID: 3052257 Review.
Cited by
-
Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression.Cell Regul. 1990 Oct;1(11):863-72. doi: 10.1091/mbc.1.11.863. Cell Regul. 1990. PMID: 2088530 Free PMC article.
-
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.Am J Pathol. 1990 Jul;137(1):135-47. Am J Pathol. 1990. PMID: 1695482 Free PMC article.
-
Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas.Mol Cell Biol. 1988 Jun;8(6):2659-63. doi: 10.1128/mcb.8.6.2659-2663.1988. Mol Cell Biol. 1988. PMID: 2841585 Free PMC article.
-
Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.Mol Cell Biol. 1991 Oct;11(10):5032-43. doi: 10.1128/mcb.11.10.5032-5043.1991. Mol Cell Biol. 1991. PMID: 1922031 Free PMC article.
-
Transforming function of proto-ras genes depends on heterologous promoters and is enhanced by specific point mutations.Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2217-21. doi: 10.1073/pnas.88.6.2217. Proc Natl Acad Sci U S A. 1991. PMID: 2006160 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources